PharmaCyte Biotech Inc PMCB:OTCQB

RT Quote | Exchange | USD
Last | 03/05/21 EST
0.0221quote price arrow up+0.0028 (+14.51%)
Volume
9,729,435
52 week range
0.00 - 0.05

...

Loading . . .

KEY STATS

  • Open0.0188
  • Day High0.0221
  • Day Low0.0162
  • Prev Close0.0193
  • 52 Week High0.05
  • 52 Week High Date03/06/20
  • 52 Week Low0.00
  • 52 Week Low Date11/04/20
  • Market Cap51.60M
  • Shares Out2.335B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.45
  • 1 Year % Change-53.57

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-10.73
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-3.456M
  • ROE (MRQ)-54.01%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.91%

EVENTS

  • Earnings Date03/15/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest PharmaCyte Biotech Inc News

There is no recent news for this security.

Latest PMCB News From Our Partners

QUOTE FINDER

Profile

MORE
PharmaCyte Biotech, Inc., formerly Nuvilex, Inc., is a clinical-stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Company's Cell-in-a-Box technology will be used as a platform upon which treatments for various types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. The Company...
Kenneth Waggoner J.D.
Chairman
Carlos Trujillo CPA
Chief Financial Officer
Address
23046 Avenida de La Carlota Ste 600
Laguna Hills, CA
92653-1537
United States